Consort Medical PLC

Consort Medical PLC
Stock Exchange London Stock Exchange
EPS
GBP0.21
Market Cap
GBP419.11 M
Shares Outstanding
49.29 M
Public Float
47.65 M

Profile

Address
Breakspear Park
Hemel Hempstead Hertfordshire HP2 4TZ
United Kingdom
Employees -
Website http://consortmedical.com
Updated 07/08/2019
Consort Medical Plc engages in the design, development, manufacture, and sale of medical drug delivery devices. It operates through two segments: Bespak and Aesica. The Bespak segment develops and produces drug delivery devices, which serves pharmaceutical companies with inhaler and auto-injector technologies.

Financials

View All

Jonathan M. Glenn
Chief Executive Officer & Executive Director
Paul Hayes
Chief Financial Officer, Secretary & Director